SCHEMBL721818

SCHEMBL721818

c1ccc(-c2ccc(-c3ccccc3)c3nsnc23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDO2 P48775 1/20 0.39
▸ BACE1 P56817 1/20 0.39
▸ ALDH1A1 P00352 4/20 0.38
▸ ALOX5 P09917 1/20 0.38
▸ HSD17B10 Q99714 3/20 0.37
▸ CYP2A6 P11509 2/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ HPGD P15428 1/20 0.37
▸ BCL2L1 Q07817 1/20 0.37
▸ CYP2B6 P20813 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ ACLY P53396 1/20 0.35
▸ METAP2 P50579 1/20 0.35
▸ DCUN1D1 Q96GG9 1/20 0.35
▸ NOTUM Q6P988 1/20 0.35
▸ ADORA3 P0DMS8 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL714013 0.95 ALDH1A1 (0.41) TDO2BACE1ALDH1A1ALOX5HSD17B10
SCHEMBL4934230 0.89 DCUN1D1 (0.40) TDO2BACE1ALDH1A1ALOX5HSD17B10
SCHEMBL18198900 0.88 CYP2A6 (0.43) TDO2ALDH1A1HSD17B10CYP2A6HPGD
SCHEMBL17659990 0.88 CYP2A6 (0.42) ALDH1A1HSD17B10CYP2A6HPGDCYP2B6
SCHEMBL23055925 0.88 MAPK1 (0.44) TDO2BACE1ALDH1A1ALOX5MAPK1
SCHEMBL18464326 0.86 NPC1 (0.43) ALDH1A1ALOX5HPGDNPC1RAB9A
SCHEMBL9927383 0.85 PSMB8 (0.42) ALDH1A1NPC1RAB9AMAPT
SCHEMBL18083028 0.84 ALDH1A1 (0.39) TDO2ALDH1A1NPC1RAB9AKDM4E
SCHEMBL19822808 0.83 RARA (0.35) ALDH1A1CYP2A6CYP2B6METAP2ADORA3
SCHEMBL711946 0.82 ALDH1A1 (0.41) ALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112409552-B Photo-induced free radical polymerization method 福州大学 2021-08-31 — — CN claimed
CN-112409552-A Photo-induced free radical polymerization method 福州大学 2021-02-26 — — CN claimed
US-20220411692-A1 COMPOSITION CONTAINING SEMICONDUCTOR NANOPARTICLES, COLOR FILTER, AND IMAGE DISPLAY DEVICE MITSUBISHI CHEMICAL CORPORATION (JP) 2022-12-29 — — US disclosed
WO-2022044759-A1 COMPOSITION CONTAINING SEMICONDUCTOR NANOPARTICLES, COLOR FILTER, AND IMAGE DISPLAY DEVICE 三菱ケミカル株式会社 2022-03-03 — — WO disclosed
CN-113880719-A Novel hole transport material based on halogenated arylamine and preparation method and application thereof 太原理工大学 2022-01-04 — — CN disclosed
CN-112409552-B Photo-induced free radical polymerization method 福州大学 2021-08-31 — — CN disclosed
CN-112409552-A Photo-induced free radical polymerization method 福州大学 2021-02-26 — — CN disclosed
EP-3312897-A1 ORGANIC ELECTROLUMINESCENT DEVICE AND MANUFACTURING METHOD THEREOF Kunshan Go-Visionox Opto-Electronics Co., Ltd. (CN) 2018-04-25 — — EP disclosed
US-9777026-B2 Branched oligoarylsilanes and method for producing same LUMINESCENT INNOVATION TECHNOLOGIES LLC (RU) 2017-10-03 — — US disclosed
US-9777026-B2 Branched oligoarylsilanes and method for producing same LUMINESCENT INNOVATION TECHNOLOGIES LLC (RU) 2017-10-03 — — US disclosed
US-9382424-B2 Highly-fluorescent and photo-stable chromophores for enhanced solar harvesting efficiency NITTO DENKO CORPORATION (JP) 2016-07-05 — — US disclosed
US-8124250-B2 includes two electrodes, an organic film layer with a substance having a benzothiadiazole skeleton, a metal oxide layer provided on the organic film layer by vacuum vapor deposition, and an interface between the pair of electrodes; stable light emitting display without sealing SEIKO EPSON CORPORATION (JP) 2012-02-28 — — US disclosed
US-20100012929-A1 ORGANIC THIN FILM TRANSISTOR DEVICE AND ORGANIC THIN FILM LIGHT-EMITTING TRANSISTOR IDEMITSU KOSAN CO., LTD. (JP) 2010-01-21 — — US disclosed
US-20090243476-A1 Acenaphthoquinoxaline Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-10-01 — — US disclosed
US-20090243476-A1 Acenaphthoquinoxaline Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-10-01 — — US disclosed
US-20090243476-A1 Acenaphthoquinoxaline Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-10-01 — — US disclosed
US-20080280162-A1 Organic electronic device SEIKO EPSON CORPORATION (JP) 2008-11-13 — — US disclosed
US-20080193794-A1 Quinoxaline Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2008-08-14 — — US disclosed
US-20080193794-A1 Quinoxaline Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2008-08-14 — — US disclosed
US-20080193794-A1 Quinoxaline Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Appliance SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2008-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090243476-A1 Acenaphthoquinoxaline Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device ACE, ACE2, NQO1 TDO2 294/4885BACE1 2310/4885ALDH1A1 102/4885
US-20080193794-A1 Quinoxaline Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Appliance SLC35E1, SLC1A2, ATP1A2 TDO2 485/4885BACE1 4076/4885ALDH1A1 92/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback